Hirak Mukhopadhyay is a Partner in the Corporate & Commercial practice group.
Hirak brings extensive expertise in Corporate and Commercial law, focusing on regulatory matters including those governed by the Foreign Exchange Management Act, 1999, FDI Policy, and approvals procurement. He specialises in guiding clients through mergers & acquisitions, both domestically and internationally, alongside advising on domestic and cross-border Joint Ventures.
Hirak has extensive experience in Corporate and Securities laws and Foreign Exchange laws including overseas investments, liberalized remittance scheme, white-collar investigations, disinvestment/spin-offs, and share/asset and slump sale transactions and has expertly guided clients on cross-border investment strategies, overseeing joint ventures, mergers/demergers/restructuring, and court arrangements.
Corporate Restructuring
Mergers and Acquisitions
Corporate and Commercial
Advised on their internal restructuring;
Advised on an acquisition of Radio One through a composite scheme of arrangement;
Advised on a cross border merger;
Advised on acquisition of Harita group companies through a composite scheme of amalgamation and arrangement;
Advised on their internal restructuring. Advised Rolls Royce group on restructuring involving the merger of various group entities in order to simplify the Indian group structure;
Advised on their restructuring and amalgamation of Satyam Cineplexes Limited with Inox Leisure Limited;
OCL India Ltd and other Dalmia group companies in connection with their group restructuring and implemented such restructuring;
Advised on their internal restructuring;
Advised on their internal restructuring,
Advised on the Scheme of Amalgamation;
Advised on a scheme involving demerger (along-with substantial investments in listed and unlisted companies) and merger amongst group companies;
Advised on one of the largest fast track mergers involving merging of 43 companies with their parent entity;
Advised on restructuring involving the merger of various group entities in order to simplify the Indian group structure.
Advised on (i) structuring e-commerce operations in India in the most tax efficient and FDI Policy compliant manner and on all the aspect of doing e-commerce business in India (ii) regulatory aspects of Indian ecommerce sector; (iii) incorporation of multiple subsidiaries in India; (iii) general aspects related to setting up business in India, including corporate compliances;
Advised on regulatory issues in India surrounding Tiktok app.;
Advised on regulatory inputs on formation of new funds / entities and assistance in various transactions in India;
Advised on investigations on possible unethical conduct by employees;
Advised on investigations on possible fraudulent conduct by employees;
Advised on compliance requirements for collection and transfer of customer data and employee data, as per the data protection laws of India;
Advised on general corporate work, including distribution agreements, aftersales agreements, and platform licence agreements;
Advised on seeking necessary regulatory approval for foreign direct investment in the telecom sector;
Advised on regulatory implications in respect of retail sale of alcoholic beverages (including norms surrounding surrogate advertising);
Advised on seeking necessary regulatory approval for foreign direct investment in the telecom sector;
Advised on responding to money laundering allegation levelled against representative office;
Confidential Indian Media Conglomerate in ED enquiries in respect of the Panama Papers / Moseck Fonseca data breach issue;
Confidential Indian Bank in responding to ED summons in respect of case registered by homebuyers against the Amrapali Group alleging siphoning off of funds;
Confidential Indian steel & power conglomerate on several matters with the ED over last 7 years;
Advised on as legal counsel as to Indian law to Shanghai Fosun Pharmaceutical (Group) Co., Ltd and Fosun Pharma Industrial Pte. Ltd, in the initial public offering of equity shares of Gland Pharma Limited;
Advised on multiple approvals under Press Note 3 of 2020;
- City Football Group
- Bank of Baroda
- Shopup group
- AI Pharmed Consultancy India Limited
- ZCL Chemicals Limited
- Confidential Indian retail client
Advised several corporates in relation to compliances pertaining to foreign direct investment including;
- Reliance Brands Limited
- City Football Group
- IIFL investments
- Sanofi
- Eucare Pharmaceuticals
- Elanco
- Ringcentral
- Ubiquity
- Maj Invest
- Ryohin Keikaku Co., Ltd
- Nippon Life Insurance Company
- Aurobindo Pharma Limited
- Lupin Limited
- Solairedirect Energy India Private Limited
- Solutions Infini Technologies (India) Private Limited
- Advent group
- Famy group
- Forever Living Imports (India) Private Limited
- India RF
Advised on structuring of grant arrangements focusing on impact investing;
Advised on reviewing and advising sales agreements;
Advised on restructuring involving the merger of various group entities in order to simplify the Indian group structure;
Advised on 100% acquisition of Columbia Asia Hospitals Private Limited;
Advised on India entry and establishing of local project office in India;
Advised on the largest Offer for Sale in India as well as advising on share buyback;
Advised on regulatory compliances in respect of single brand retail trading operations in India;
Advised on its acquisition of controlling stake in Next Mediaworks Limited and Next Radio Limited;
Advised on public procurement process in India and assisting in requisite regulator registrations;
Advised on the sale of its subsidiaries and other solar assets to MAIF Investments India 2 Pte Ltd and MAIF Investments India Pte Ltd;
Advised on long term export arrangements, and supply agreements;
Several corporates and/or providing legal opinion on various issues pertaining to provisions of Companies Act/ FEMA / FDI regime/ Income Tax, including:
- Dalmia Bharat Group
- Hindustan Times group
- Schlumberger
- Advent group
- JK Group
- Jindal Group
- SIEMENS